Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamera J Corte

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
The Lancet. Respiratory Medicine|October 17, 2017
Palliative care in interstitial lung disease: living wellMichael Kreuter, Elisabeth Bendstrup, Anne-Marie Russell, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2014
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumoniaTamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, et al.
BMJ Open Respiratory Research|December 3, 2021
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisJohn A Mackintosh, Maria Pietsch, Viviana Lutzky, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 21, 2021
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP studySteven D Nathan, Vincent Cottin, Juergen Behr, et al.
Respirology (Carlton, Vic.)|July 25, 2022
Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosisStephen M Humphries, John A Mackintosh, Helen E Jo, et al.
Respirology (Carlton, Vic.)|January 8, 2026
Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary FibrosisJohn A Mackintosh, Simon L F Walsh, Mario Silva, et al.
Respirology (Carlton, Vic.)|February 7, 2025
Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated PatientsRoger M Li, Dino B A Tan, Chantalia Tedja, et al.
Plos One|March 31, 2023
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung diseaseAlyson W Wong, Huiying Sun, Ingrid A Cox, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Respiratory Research|December 5, 2025
A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocolCarly Barton, Mariana Hoffman, Narelle S Cox, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
The Lancet. Respiratory Medicine|October 17, 2017
Palliative care in interstitial lung disease: living wellMichael Kreuter, Elisabeth Bendstrup, Anne-Marie Russell, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2014
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumoniaTamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, et al.
BMJ Open Respiratory Research|December 3, 2021
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisJohn A Mackintosh, Maria Pietsch, Viviana Lutzky, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 21, 2021
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP studySteven D Nathan, Vincent Cottin, Juergen Behr, et al.
Respirology (Carlton, Vic.)|July 25, 2022
Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosisStephen M Humphries, John A Mackintosh, Helen E Jo, et al.
Respirology (Carlton, Vic.)|January 8, 2026
Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary FibrosisJohn A Mackintosh, Simon L F Walsh, Mario Silva, et al.
Respirology (Carlton, Vic.)|February 7, 2025
Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated PatientsRoger M Li, Dino B A Tan, Chantalia Tedja, et al.
Plos One|March 31, 2023
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung diseaseAlyson W Wong, Huiying Sun, Ingrid A Cox, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Respiratory Research|December 5, 2025
A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocolCarly Barton, Mariana Hoffman, Narelle S Cox, et al.
Pageof 16